MergerJun 24, 2026, 12:21 PM
LakeShore Biopharma Completes Going Private Transaction
AI Summary
LakeShore Biopharma Co., Ltd. announced the completion of its going private transaction through a merger with Oceanpine Merger Sub Inc. As a result, the company is now a wholly owned subsidiary of Oceanpine Skyline Inc. and will cease to be publicly traded. Shareholders received US$0.066 in cash for each ordinary share, and the company plans to suspend its SEC reporting obligations by filing a Form 15.
Key Highlights
- Merger with Oceanpine Merger Sub Inc. completed.
- LakeShore Biopharma is now a wholly owned subsidiary of Oceanpine Skyline Inc.
- Shareholders received US$0.066 in cash per ordinary share.
- Company will cease to be a publicly traded entity.
- LakeShore Biopharma intends to file Form 15 to suspend SEC reporting obligations.
- FINRA is expected to remove the company's trading symbols from OTC Pink.
Price Impact
More from LSBCF